Vedall Pharma Private Limited

Vedall Pharma Private Limited - chemicals in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24234TN2010PTC076476 Incorporated 06 July 2010 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2024
₹93.43 Lakh
▼ 44% YoY
Net profit · FY 2024
₹84,684
Net margin 0.9%
EBITDA · FY 2024
₹3.96 Lakh
EBITDA margin 4.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Vedall Pharma Private Limited

Data last updated:

Vedall Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 06 July 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24234TN2010PTC076476. Its GSTIN is 33AAECV8588M1ZI (Tamil Nadu).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sajid Mohammed (Whole-Time Director) and Aliya Peeran (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at New No. 22A Old No. 13 New Bangaru Colony K Nagar West, Chennai, Tamil Nadu, India – 600078.

As per the financials filed for FY 2024, the company reported a revenue of ₹93.43 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net profit of ₹84,684 (net margin 0.9%) and EBITDA of ₹3.96 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 11% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Vedall Pharma Private Limited
CIN U24234TN2010PTC076476
Registration Number 076476
Incorporation Date 06 July 2010
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    New No. 22A Old No. 13 New Bangaru Colony K Nagar West, Chennai, Tamil Nadu, India – 600078
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Vedall Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Vedall Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Vedall Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Vedall Pharma Private Limited

The main business activity of Vedall Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Vedall Pharma Private Limited FY 2025 filings available

Vedall Pharma Private Limited reported revenue of ₹93.43 Lakh (down 44% YoY) for FY 2024.

Revenue · FY 2024
₹93.43 Lakh ▼ 44%
Net profit · FY 2024
₹84,684 margin 0.9%
EBITDA · FY 2024
₹3.96 Lakh margin 4.2%

Compounded Annual Growth Rate (CAGR) of Vedall Pharma Private Limited

Revenue CAGR growth
1 year
▼ 44%
3 years · compounded
▲ 3%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 60%
3 years · compounded
▲ 4%
5 years · compounded
▲ 7%

Revenue fell 44% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Vedall Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹3.96 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹84,684••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Vedall Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin4.2%••••••••••••••••
Net Profit Margin0.9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vedall Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Vedall Pharma Private Limited

Vedall Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mohammed NayeemDirector06 Jul 201016 Years 3 MonthsCurrent
Sajid MohammedWhole-Time Director06 Jul 201016 Years 3 MonthsCurrent
Aliya PeeranWhole-Time Director12 Dec 201510 Years 10 MonthsCurrent

Peer Comparison of Vedall Pharma Private Limited

Vedall Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Turin Chemicals Private Limited₹96.46 Lakh (FY 2023)••••••••62.0%••••Telangana, India
Glenvet Animal Health India Private Limited₹95.6 Lakh (FY 2024)••••••••6.0%••••Pune, Maharashtra, India
Nuculeus Labs Care Private Limited₹95.38 Lakh (FY 2024)••••••••-31.0%••••Jaipur, Rajasthan, India
Trivet Pharmaceuticals Private Limited₹94.96 Lakh (FY 2024)••••••••-7.0%••••Karnal, Haryana, India
Abiocis Bio-Science Private Limited₹94.31 Lakh (FY 2023)••••••••-82.0%••••Secunderabad, Telangana, India
Vedall Pharma Private Limited this company₹93.43 Lakh (FY 2024)••••••••-44.0%••••Chennai, Tamil Nadu, India
Precure Life Science Private Limited₹90.94 Lakh (FY 2024)••••••••7.0%••••Palanpur, Gujarat, India
Anicrest Veterinarian Private Limited₹89.15 Lakh (FY 2025)••••••••••••Noida, Uttar Pradesh, India
Lancovet Private Limited₹80.23 Lakh (FY 2025)••••••••64.0%••••Rajpura, Punjab, India
Kanchem Pharmaceuticals Private Limited₹79.77 Lakh (FY 2025)••••••••-68.0%••••Ahmedabad, Gujarat, India
Pacific Herbal Products Private Limited₹79.71 Lakh (FY 2024)••••••••11.0%••••Nandod, Gujarat, India

Peers are the five companies nearest above and the five nearest below Vedall Pharma by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Vedall Pharma Private Limited

Vedall Pharma Private Limited is audited by P Ganesan & Co for the financial year 2017.

NameStatusAppointment DateCessation Date
P Ganesan & CoLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Vedall Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Vedall Pharma Private Limited

Vedall Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Vedall Pharma Private Limited

Employment history and EPFO contributions of people linked to Vedall Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Vedall Pharma Private Limited

Vedall Pharma Private Limited has 6 board changes on record since 2010: 3 appointments and 3 cessations. The latest: Anser Mohammed Salahuddin ceased to be Director on 10 Jan 2022.

AGM
Vedall Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vedall Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Anser Mohammed Salahuddin ceased to be Director.
Appointed
Aliya Peeran was appointed as Whole-Time Director.
Ceased
Aliya Peeran ceased to be Director.
Ceased
Sajid Mohammed ceased to be Director.
Appointed
Mohammed Nayeem was appointed as Director.
Appointed
Sajid Mohammed was appointed as Whole-Time Director.
Incorporation
06 Jul 2010
Vedall Pharma Private Limited was registered on 06 Jul 2010 with Roc Chennai & aged 16 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Vedall Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Vedall Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Vedall Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Vedall Pharma Private Limited

Vedall Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAECV8588M1ZITamil NaduActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Vedall Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vedall Pharma Private Limited

Vedall Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in chemical products, within the chemicals industry. It was incorporated on 06 July 2010 (16+ years old) and is registered under CIN U24234TN2010PTC076476.

Vedall Pharma reported revenue of ₹93.43 Lakh for FY 2024 (down 44% YoY).

Vedall Pharma has 3 current directors:

Vedall Pharma reported a net profit of ₹84,684 (net margin 0.9%) and EBITDA of ₹3.96 Lakh (EBITDA margin 4.2%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Vedall Pharma is 3% over three years and 11% over five years. In the latest year (FY 2024) revenue fell 44%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Vedall Pharma is 33AAECV8588M1ZI, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Vedall Pharma is U24234TN2010PTC076476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vedall Pharma was incorporated on 06 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Vedall Pharma by revenue are Turin Chemicals Private Limited, Glenvet Animal Health India Private Limited, Nuculeus Labs Care Private Limited, Trivet Pharmaceuticals Private Limited, Abiocis Bio-Science Private Limited and 5 more, all in the Pharma industry (Animal Pharma).

Anser Mohammed Salahuddin ceased to be Director on 10 Jan 2022. Aliya Peeran was appointed as Whole-Time Director on 12 Dec 2015. Aliya Peeran ceased to be Director on 12 Dec 2015. Vedall Pharma has 6 board changes on record in total.

The registered office of Vedall Pharma is at New No. 22A Old No. 13 New Bangaru Colony K Nagar West, Chennai, Tamil Nadu, India – 600078.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available